Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,297.60
(
-1.78%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
108.32
(
3.72%
)
Bitcoin
69,860.00
(
-0.06%
)
News Focus
News Focus
Post# of 257264
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

acgood

Send PM Follow Ignore
Followers 17
Posts 1093
Boards Moderated 0
Alias Born 05/12/2007

acgood

Re: jq1234 post# 142682

Saturday, 05/26/2012 2:27:50 PM

Saturday, May 26, 2012 2:27:50 PM

Post# of 257264
ALNY and ISIS have not gone into specifics of TTR pivotal trial design - both are saying that they are still in discussions with regulators and KOLs. ALNY is also running a phase 2 trial in patients first before pivotal.

Opinions and comments may have been previously posted @BioDueDiligence, at www.biotechduediligence.com, or disseminated to Chimera Research Group subscribers.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today